Glucose-lowering medications and post-dementia survival in patients with diabetes and dementia
Manuscript Number:
21-5337R1
Author(s):
Michael Alvarsson, Maria Eriksdotter, Sara Garcia-Ptacek, Niklas Hammar, Dorota Religa, Emilia Schwertner, Juraj Secnik, Bengt Winblad, Hong Xu
Disclosures
Michael Alvarsson
Lecture Fees:
I have received lecture fees from Novo Nordisk, Eli Lilly and AstraZeneca.
Maria Eriksdotter
Lecture Fees:
Honoraria for Speaker on Covid-19 and Aging at Symposia April 22, 2021 organized by Journal of the Swedish Medical Association
Honoraria for Speaker on Dementia at Educational event organized by Gothia Fortbildning Feb 6 2020
Honoraria for lecture on dementia in symposia Oct 24 2019, organized by Journal of the Swedish Medical Association
Sara Garcia-Ptacek
Equity:
AstraZeneca, Pfizer, Moderna, Camurus as pension savings
Niklas Hammar
Consulting Fees:
Senior Advisor Swedish Orphan Biovitrum consulting fee
Equity:
AstraZeneca shares
Dorota Religa
Nothing to Disclose
Emilia Schwertner
Nothing to Disclose
Juraj Secnik
Nothing to Disclose
Bengt Winblad
Consulting Fees:
I am paid for SAB for:
Alzinova, Alzecure, Axon Neuroscience, Biogen.